Found: 20
Select item for more details and to access through your institution.
Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ).
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0068-z
- By:
- Publication type:
- Article
Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ).
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0064-3
- By:
- Publication type:
- Article
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 971, doi. 10.2147/PPA.S159620
- By:
- Publication type:
- Article
Preference for pharmaceutical formulation and treatment process attributes.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 1385, doi. 10.2147/PPA.S101821
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 1, doi. 10.1111/dom.13999
- By:
- Publication type:
- Article
Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 355, doi. 10.1111/dom.13902
- By:
- Publication type:
- Article
Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD).
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 8, p. 1437, doi. 10.1007/s10198-023-01667-7
- By:
- Publication type:
- Article
Health state utilities associated with treatment for transfusion-dependent β-thalassemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes.
- Published in:
- Patient, 2022, v. 15, n. 3, p. 367, doi. 10.1007/s40271-022-00578-8
- By:
- Publication type:
- Article
A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple Sclerosis.
- Published in:
- Medical Decision Making, 2020, v. 40, n. 7, p. 897, doi. 10.1177/0272989X20951782
- By:
- Publication type:
- Article
Acute and chronic impact of cardiovascular events on health state utilities.
- Published in:
- BMC Health Services Research, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12913-015-0772-9
- By:
- Publication type:
- Article
Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetes.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00614-7
- By:
- Publication type:
- Article
Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD).
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-022-00535-x
- By:
- Publication type:
- Article
A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 9, p. 1451, doi. 10.1007/s13300-023-01426-0
- By:
- Publication type:
- Article
Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 1, p. 319, doi. 10.1007/s13300-019-00718-8
- By:
- Publication type:
- Article
Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 7, p. 2033, doi. 10.1007/s11136-021-02808-2
- By:
- Publication type:
- Article
Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation.
- Published in:
- 2017
- By:
- Publication type:
- journal article